Anthony J. Doyle
Overview
Anthony J. Doyle received an average of $4M in total compensation, including $418K in salary, at BioCryst Pharmaceuticals between 2020 and 2021.
Source: SEC filing on April 25, 2022.
Related executives
We found 16 more executives who work or worked at BioCryst Pharmaceuticals.
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
Helen Thackray
BioCryst Pharmaceuticals
Chief R&D Officer
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
Yarlagadda Babu
BioCryst Pharmaceuticals
Chief Discovery Officer
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
Alane Barnes
BioCryst Pharmaceuticals